lactic acid has been researched along with tacrolimus in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (10.53) | 18.2507 |
| 2000's | 6 (31.58) | 29.6817 |
| 2010's | 9 (47.37) | 24.3611 |
| 2020's | 2 (10.53) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Andrade, J; Bedoya, FJ; Conde, M; Santa Maria, C; Sobrino, F | 1 |
| Bouvet, JP; Giuliano, A; Marone, G; Patella, V | 1 |
| Kimura, H; Kunou, N; Nozaki, M; Ogura, Y; Okabe, K; Sakurai, E | 1 |
| Costa, G; Demetris, AJ; Fung, JJ; Gutierrez, J; Ishii, T; Kelly, DM; Lee, MC; Madariaga, JR; Marcos, A; Subbotin, V; Totsuka, E; Venkataraman, R; Yin, L; Zhu, Y | 1 |
| Chen, JQ; Fei, WL; Quan, DP; Yuan, J; Zhou, SY | 1 |
| Duncker, D; Sorop, O; van Beusekom, H; van der Giessen, W; Weymaere, M | 1 |
| Alluin, O; Chabas, JF; Decherchi, P; Feron, F; Garcia, S; Lavaut, MN; Legré, R; Magalon, G; Marqueste, T; Rao, G | 1 |
| Agostoni, P; Birkemeyer, R; Grube, E; Haine, S; Haude, M; Jung, W; Müller, R; Sarno, G; van Langenhove, G; Verheye, S; Vrints, C; Wijns, W; Willems, T | 1 |
| Da Silva, GR; Fialho, SL; Fulgêncio, GO; Silva-Cunha, A; Souza, MC; Souza, PA | 1 |
| Borschel, GH; Gordon, T; Shoichet, MS; Tajdaran, K | 1 |
| Desai, JL; Mistry, NP; Thakkar, HP | 1 |
| Higashi, Y; Kojima, R; Maeda, M; Oku, N; Tasaki, H; Umejima, H; Watanabe, S; Yoshida, T | 1 |
| Gupta, B; Jeong, JH; Kim, JO; Kim, MS; Pathak, S; Pham, TT; Poudel, BK; Regmi, S; Thapa, RK; Tran, TH; Yong, CS | 1 |
| Choi, HG; Hwang, HS; Lee, C; Lee, EH; Lee, ES; Lee, S; Seo, J; Thao, LQ; Youn, YS | 1 |
| Agarwal, J; Gale, BK; Ho, S; Labroo, P; Sant, H; Shea, J | 1 |
| Ahn, CH; Bae, YK; Byun, Y; Choi, JU; Jeong, JH; Kim, JO; Nguyen, HT; Nguyen, TT; Park, MH; Park, PH; Pathak, S; Pham, TT; Regmi, S; Tran, TH; Yong, CS; Yook, S | 1 |
| Ding, Y; Fan, B; Mao, Z; Wang, W; Wang, Y; Wu, J; Yang, Y | 1 |
| Aandahl, EM; Bergmann, GB; Berstad, AE; Brabrand, K; Dorenberg, E; Hagen, G; Haugaa, H; Horneland, R; Jenssen, TG; Kjøsen, G; Line, PD; Nordheim, E; Pischke, SE; Rydenfelt, K; Tønnessen, TI | 1 |
2 trial(s) available for lactic acid and tacrolimus
| Article | Year |
|---|---|
The ProLimus trial: a prospective, non-randomised, multicentre trial to evaluate the safety and clinical performance of the pimecrolimus eluting stent system (ProGenic).
Topics: Aged; Angioplasty, Balloon, Coronary; Belgium; Cardiovascular Agents; Chromium Alloys; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Female; Germany; Humans; Lactic Acid; Male; Middle Aged; Myocardial Infarction; Polyesters; Polymers; Prospective Studies; Prosthesis Design; Severity of Illness Index; Tacrolimus; Thrombosis; Time Factors; Treatment Outcome; Ultrasonography, Interventional | 2009 |
Early detection of complications in pancreas transplants by microdialysis catheters, an observational feasibility study.
Topics: Adult; Antilymphocyte Serum; Catheters, Indwelling; Early Diagnosis; Feasibility Studies; Female; Glucose; Glycerol; Graft Rejection; Hematoma; Humans; Immunosuppressive Agents; Lactic Acid; Male; Microdialysis; Middle Aged; Monitoring, Physiologic; Mycophenolic Acid; Pancreas Transplantation; Pyruvic Acid; Tacrolimus; Venous Thrombosis | 2021 |
17 other study(ies) available for lactic acid and tacrolimus
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Inhibitory effect of cyclosporin A and FK506 on nitric oxide production by cultured macrophages. Evidence of a direct effect on nitric oxide synthase activity.
Topics: Amino Acid Oxidoreductases; Animals; Cells, Cultured; Cyclosporine; Dose-Response Relationship, Drug; Kinetics; Lactates; Lactic Acid; Macrophages, Peritoneal; Male; Mice; Mice, Inbred Strains; Nitric Oxide; Nitric Oxide Synthase; Pentose Phosphate Pathway; Tacrolimus | 1995 |
Endogenous superallergen protein Fv induces IL-4 secretion from human Fc epsilon RI+ cells through interaction with the VH3 region of IgE.
Topics: Adult; Allergens; Antibodies, Anti-Idiotypic; Basophils; Cyclosporine; Histamine Release; Humans; Immunoglobulin E; Immunoglobulin Heavy Chains; Immunoglobulin M; Immunoglobulin Variable Region; Interleukin-4; Kinetics; Lactic Acid; Lung; Lymphokines; Mast Cells; Myeloma Proteins; Receptors, IgE; RNA, Messenger; Sialoglycoproteins; Superantigens; Tacrolimus | 1998 |
Scleral plug of biodegradable polymers containing tacrolimus (FK506) for experimental uveitis.
Topics: Absorbable Implants; Animals; Antigens, Bacterial; Aqueous Humor; Biocompatible Materials; Cell Count; Chromatography, High Pressure Liquid; Disease Models, Animal; Drug Delivery Systems; Electroretinography; Eye Proteins; Immunosuppressive Agents; Lactic Acid; Mycobacterium tuberculosis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rabbits; Sclera; Sclerostomy; Tacrolimus; Uveitis; Vitreous Body | 2003 |
Porcine partial liver transplantation: a novel model of the "small-for-size" liver graft.
Topics: Animals; Aspartate Aminotransferases; Bilirubin; Female; Graft Survival; Immunosuppressive Agents; Lactic Acid; Liver; Liver Regeneration; Liver Transplantation; Postoperative Period; Reproducibility of Results; Swine; Tacrolimus; Vascular Diseases | 2004 |
Preliminary study of the effect of FK506 nanospheric-suspension eye drops on rejection of penetrating keratoplasty.
Topics: Animals; Cornea; Dexamethasone; Disease Models, Animal; Female; Graft Rejection; Graft Survival; Immunohistochemistry; Immunosuppressive Agents; In Vitro Techniques; Keratoplasty, Penetrating; Lactic Acid; Nanospheres; Ophthalmic Solutions; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rabbits; Rats; Rats, Sprague-Dawley; Rats, Wistar; Tacrolimus; Time Factors | 2008 |
The neointimal response to stents eluting tacrolimus from a degradable coating depends on the balance between polymer degradation and drug release.
Topics: Angioplasty, Balloon, Coronary; Animals; Coated Materials, Biocompatible; Coronary Vessels; Disease Models, Animal; Drug-Eluting Stents; Elastin; Endothelium, Vascular; Immunohistochemistry; Immunosuppressive Agents; Lactic Acid; Metals; Nitric Oxide Synthase Type III; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Sus scrofa; Swine; Swine, Miniature; Tacrolimus; Tunica Intima; Tunica Media; Vasculitis | 2008 |
FK506 induces changes in muscle properties and promotes metabosensitive nerve fiber regeneration.
Topics: Animals; Disease Models, Animal; Growth Cones; Immunosuppressive Agents; Lactic Acid; Male; Muscle Fibers, Fast-Twitch; Nerve Regeneration; Peripheral Nerve Injuries; Peripheral Nerves; Peripheral Nervous System Diseases; Peroneal Nerve; Potassium Chloride; Rats; Rats, Sprague-Dawley; Recovery of Function; Sensory Receptor Cells; Tacrolimus; Treatment Outcome | 2009 |
Tacrolimus-loaded PLGA implants: in vivo release and ocular toxicity.
Topics: Animals; Biocompatible Materials; Choroid; Drug Delivery Systems; Feasibility Studies; Female; Immunosuppressive Agents; Intravitreal Injections; Lactic Acid; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Prostheses and Implants; Rabbits; Retina; Sclera; Tacrolimus; Uveitis; Vitreous Body | 2014 |
A novel polymeric drug delivery system for localized and sustained release of tacrolimus (FK506).
Topics: Animals; Cells, Cultured; Delayed-Action Preparations; Fibrin; Ganglia, Spinal; Lactic Acid; Neurites; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Regenerative Medicine; Tacrolimus | 2015 |
Formulation and evaluation of tacrolimus-loaded galactosylated Poly(lactic-co-glycolic acid) nanoparticles for liver targeting.
Topics: Animals; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Drug Liberation; Female; Galactose; Immunosuppressive Agents; Lactic Acid; Liver; Magnetic Resonance Spectroscopy; Male; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Wistar; Spectroscopy, Fourier Transform Infrared; Tacrolimus; Tissue Distribution | 2015 |
Release mechanisms of tacrolimus-loaded PLGA and PLA microspheres and immunosuppressive effects of the microspheres in a rat heart transplantation model.
Topics: Animals; Drug Liberation; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Lactic Acid; Male; Microspheres; Polyesters; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rats, Inbred Lew; Tacrolimus | 2015 |
Preparation of High-Payload, Prolonged-Release Biodegradable Poly(lactic-co-glycolic acid)-Based Tacrolimus Microspheres Using the Single-Jet Electrospray Method.
Topics: Animals; Calorimetry, Differential Scanning; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Drug Carriers; Drug Liberation; Lactic Acid; Microscopy, Electron, Scanning; Microspheres; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Spectroscopy, Fourier Transform Infrared; Structure-Activity Relationship; Surface Properties; Tacrolimus; X-Ray Diffraction | 2016 |
Treatment of bleomycin-induced pulmonary fibrosis by inhaled tacrolimus-loaded chitosan-coated poly(lactic-co-glycolic acid) nanoparticles.
Topics: Administration, Inhalation; Aerosols; Animals; Bleomycin; Chitosan; Collagen; Hydroxyproline; Imaging, Three-Dimensional; Lactic Acid; Lung; Male; Mice, Inbred C57BL; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pulmonary Fibrosis; Static Electricity; Surface Properties; Tacrolimus; X-Ray Diffraction | 2016 |
Controlled Delivery of FK506 to Improve Nerve Regeneration.
Topics: Animals; Axons; Chick Embryo; Ganglia, Spinal; Lactic Acid; Nerve Regeneration; Neurites; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Tacrolimus | 2016 |
Tissue adhesive FK506-loaded polymeric nanoparticles for multi-layered nano-shielding of pancreatic islets to enhance xenograft survival in a diabetic mouse model.
Topics: Animals; Coated Materials, Biocompatible; Collagen; Diabetes Mellitus, Experimental; Dihydroxyphenylalanine; Disease Models, Animal; Graft Survival; Heterografts; Islets of Langerhans; Lactic Acid; Male; Mice, Inbred C57BL; Nanoparticles; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rats, Sprague-Dawley; Tacrolimus; Tissue Adhesives; Tissue Survival; Transplantation, Heterologous | 2018 |
Inflammation-targeting polymeric nanoparticles deliver sparfloxacin and tacrolimus for combating acute lung sepsis.
Topics: Animals; Anti-Bacterial Agents; Drug Carriers; Endothelial Cells; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Immunosuppressive Agents; Inflammation; Lactic Acid; Lung; Mice; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Sepsis; Tacrolimus | 2020 |